LD
Lipe & Dalton Portfolio holdings
AUM
$185M
This Quarter Return
+4.56%
1 Year Return
+17.63%
3 Year Return
+59.66%
5 Year Return
+128.45%
10 Year Return
+273.47%
AUM
$138M
AUM Growth
+$138M
(-1.7%)
Cap. Flow
-$7.73M
Cap. Flow
% of AUM
-5.6%
Top 10 Holdings %
Top 10 Hldgs %
37.97%
Holding
83
New
8
Increased
13
Reduced
37
Closed
3
Top Buys
| 1 |
CVS Health
CVS
|
$2.69M |
| 2 |
Qualcomm
QCOM
|
$2.39M |
| 3 |
SRCLP
Stericycle, Inc
SRCLP
|
$625K |
| 4 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$546K |
| 5 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$447K |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
$6.48M |
| 2 |
AT&T
T
|
$2.33M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$2.16M |
| 4 |
Deere & Co
DE
|
$1.37M |
| 5 |
RAI
Reynolds American Inc
RAI
|
$1.36M |
Sector Composition
| 1 | Technology | 21.02% |
| 2 | Healthcare | 19.72% |
| 3 | Financials | 15.92% |
| 4 | Industrials | 9.26% |
| 5 | Communication Services | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gilead Sciences
GILD
$139B
| $2.62M | 1.9% |
38,615
+2,360
| +7% | +$160K |
|
27
Emerson Electric
EMR
$73.6B
| $2.49M | 1.8% |
41,565
-120
| -0.3% | -$7.18K |
|
|
28
Qualcomm
QCOM
$169B
| $2.39M | 1.73% |
+41,645
| New | +$2.39M |
|
29
Cigna
CI
$80.8B
| $2.17M | 1.57% |
14,835
-1,035
| -7% | -$152K |
|
30
BCE
BCE
$23.1B
| $1.93M | 1.39% |
43,516
-101
| -0.2% | -$4.47K |
|
31
iShares MSCI EAFE ETF
EFA
$65.2B
| $1.77M | 1.28% |
28,470
+6,900
| +32% | +$430K |
|
|
SRCLP
32
DELISTED
Stericycle, Inc
SRCLP
| $1.55M | 1.12% |
21,800
+8,800
| +68% | +$625K |
|
33
Medtronic
MDT
$120B
| $1.51M | 1.09% |
18,723
-660
| -3% | -$53.2K |
|
|
AGN.PRA
34
DELISTED
Allergan plc.
AGN.PRA
| $1.49M | 1.08% |
1,762
+645
| +58% | +$546K |
|
35
Exxon Mobil
XOM
$487B
| $1.41M | 1.02% |
17,247
| – | – |
|
36
Visa
V
$677B
| $1.32M | 0.96% |
14,900
-925
| -6% | -$82.2K |
|
37
Fortive
FTV
$16B
| $1.09M | 0.79% |
18,174
-712
| -4% | -$42.9K |
|
38
Novo Nordisk
NVO
$253B
| $833K | 0.6% |
24,299
| – | – |
|
39
iShares MSCI Emerging Markets ETF
EEM
$18.9B
| $820K | 0.59% |
20,812
| – | – |
|
40
VF Corp
VFC
$5.84B
| $811K | 0.59% |
14,762
-600
| -4% | -$33K |
|
41
Sherwin-Williams
SHW
$90.2B
| $774K | 0.56% |
2,494
| – | – |
|
42
Microsoft
MSFT
$3.75T
| $766K | 0.55% |
11,634
| – | – |
|
43
Schlumberger
SLB
$54.3B
| $570K | 0.41% |
7,300
-1,000
| -12% | -$78.1K |
|
44
Oracle
ORCL
$630B
| $557K | 0.4% |
12,490
-250
| -2% | -$11.1K |
|
|
BIVV
45
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $447K | 0.32% |
+8,212
| New | +$447K |
|
46
Eaton
ETN
$134B
| $433K | 0.31% |
5,845
| – | – |
|
47
Johnson & Johnson
JNJ
$429B
| $352K | 0.25% |
2,823
-400
| -12% | -$49.9K |
|
48
AbbVie
ABBV
$371B
| $350K | 0.25% |
5,370
-140
| -3% | -$9.13K |
|
49
Community Bank
CBU
$3.13B
| $312K | 0.23% |
5,667
| – | – |
|
|
50
AT&T
T
$210B
| $309K | 0.22% |
7,440
-56,190
| -88% | -$2.33M |
|